Facebook Twitter Instagram
    Trending
    • Interview: Lewis Thompson, VP Sport
    • En Garde!
    • BUWRU Still on Top
    • Hidden Histories: With The Archaeology Society
    • Beabadoobee Concert Review: Welcome to Beatopia
    • Taylor Swift: Midnights Review – The Stories of 13 Sleepless Nights
    • Claire Concert Review: Claire Cottrill in Concert!
    • Is There Hope For Percy Jackson?
    Facebook Twitter Instagram YouTube Flickr
    Seren
    • News & Politics
      1. Local News
      2. UK News
      3. Uni News
      4. World News
      5. Politics
      6. Comment
      7. Business
      Featured

      SABB Election: The Full Result Breakdown

      By Emily ReadMarch 20, 20210
      Recent

      Redevelopment plans and the culture of Bangor

      October 28, 2022

      Immediate closure of Menai Bridge following reports of structural integrity issues

      October 28, 2022

      Racial abuse victim calls for harsher sentencing following nightclub assault

      October 28, 2022
    • Arts & Culture
      1. Books
      2. Games
      3. Film
      4. Music
      5. TV
      6. Creative Corner
      Featured

      Bangor alumni podcast earns Hollywood cameo & BBC features

      By Amelia SmithMarch 7, 20210
      Recent

      Beabadoobee Concert Review: Welcome to Beatopia

      October 29, 2022

      Taylor Swift: Midnights Review – The Stories of 13 Sleepless Nights

      October 29, 2022

      Claire Concert Review: Claire Cottrill in Concert!

      October 29, 2022
    • Lifestyle
      1. Fashion
      2. Food and Drink
      3. Social
      4. Health and Beauty
      5. Travel
      Featured

      Country Highlight: The Netherlands

      By Emily ShoultsMay 6, 20220
      Recent

      Gilmore Garms

      October 28, 2022

      Fleeces and Funk

      October 28, 2022

      Cheerleading: Getting your kit together

      October 28, 2022
    • Discovery
      1. Science
      2. Environment
      3. History
      4. International
      Featured

      Brewing up a Storm: The History of Guinness

      By Emily ReadMarch 20, 20210
      Recent

      North Wales Ramblings

      October 28, 2022

      Hamza Yassin: The Hard Work That Is Making Luck Happen

      October 28, 2022

      Student’s Union Hosts Repair Cafe for Sustainability Awareness Week

      October 28, 2022
    • Sport
      1. Varsity 2019
      2. Varsity 2018
      3. Varsity 2017
      4. Varsity 2016
      5. Varsity 2015
      6. Varsity 2014
      7. Varsity 2013
        • Varsity 2013 Results
        • Varsity 2013 – In tweets
      Featured

      Bangor Muddogs’ American Football: a young woman finding her place

      By Jade HillMarch 23, 20210
      Recent

      Interview: Lewis Thompson, VP Sport

      October 29, 2022

      En Garde!

      October 29, 2022

      BUWRU Still on Top

      October 29, 2022
    • Students’ Union
      1. Union News
      2. Societies
      3. Volunteering
      4. Clubs
      Featured

      INTERVIEW: Be Period Positive

      By Caroline CartmillMarch 17, 20210
      Recent

      Interview: Lewis Thompson, VP Sport

      October 29, 2022

      En Garde!

      October 29, 2022

      BUWRU Still on Top

      October 29, 2022
    • Issues
      • Current Issue
      • This year’s issues
      • Last year’s issues
      • Seren Archive
      • Seren Teams
    Seren
    Home»News & Politics»Martin Shkreli’s Daraprim Scandal
    News & Politics

    Martin Shkreli’s Daraprim Scandal

    Kayleigh LavorniaBy Kayleigh LavorniaNovember 17, 2017Updated:November 18, 2017No Comments4 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Martin Shkreli, founder and former CEO of Turing Pharmaceuticals, sparked quite a bit of controversy with the candidates of the presidential election of 2016 and in the United States alike over his company’s decision to raise the price of an HIV/AIDS drug by over 5000%. Overnight, the company increased the price of daraprim, which is used in treating PCP, a type of pneumonia caused by a yeast-like fungus, and a number of other smaller medical issues, from $13.50 to $750 USD a tablet. However, there was a point in time when daraprim only cost $1 a pill. According to IMS Health, prior to the sale of daraprim to Turing, usage of the pill had gone down tremendously, from 12,700 in 2010 to 8,820 in 2014, which conflicts with the fact that profits  from the sale of this drug increased from $667,000 to $9.9 million respectively. Inflation as drastic as this is not in any way exclusively an issue with Turing Pharmaceuticals, but is an ongoing and rampant issue within the private pharmaceutical industry.

    Another pivotal example of this behavior is with the rise in price of Epipens over the last decade. Epipens are typically used to combat the effects of potentially deadly allergic reactions, and are produced by a company called Mylan. In January of 2009, the cost of a two pack of Epipens totaled $100. Come May of 2016, the exact same pack of the medicine totaled $600, which is a 500% increase in price over a 6 year time frame. Although this is not quite on the same scale as Shkreli’s price increase, it is still quite notable, and potentially crippling for patients. However, in an interview with Martin Shkreli on CBS news, Shkreli defended the company’s decision to increase the price of the drug, claiming that the company that manufactures Epipens makes 8 cents for every dollar they sell. Given that Mylan is a generic medicine retailer, this is considered a low price for the product, but on the other hand it is still important to keep sympathy for the patients who cannot afford medication in mind.

    From the price increase of cycloserine reaching $10,800 from $500, to a 500% increase in the price of Isuprel, this is not an uncommon issue within the pharmaceutical community. Although it is easy to attack these companies based off of the basic moral arguments regarding such hefty price increases, there are some compelling arguments in favor of the corporations. Many of the companies that manufacture drugs use their revenue to do extensive research on enhancing products and creating new drugs for diseases that may otherwise be untreatable. Other companies, such as Turing Pharmaceuticals, produce drugs that only a small percentage of the population need to take each year, which means that cost of production far outweighs the revenue from the sale of the drug. This creates an environment where major pharmaceutical companies ignore smaller drugs in favor of big ticket items, and companies who do tackle these smaller drugs must increase the price drastically to make a profit.

    In the most unideal of scenarios, a company might even cease the production of a drug due to lack of revenue, leaving those who need the drug in a dire state. In this case, it may be argued that $750 for a drug, although a high price to pay, is still better than not having access to the drug at all. Still for some who cannot afford the medicine, only being able to access a drug at $750 a pill may as well equivalent to not being able to access the drug. Yet at the end of the day, given the privatization of pharmaceuticals that the United States has in place, these companies are meant to make a profit, even with the health and safety of patients at the forefront of their agenda. Given these terms, it can confidently be said that although these price increases may be detrimental to some patients, there are a lot more aspects to this predicament that have not been thoroughly explored yet, and the incidents in question cannot be adequately addressed until these aspects have been explored.

     

    daraprim Epipens HIV pharmaceutical Shkreli
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Kayleigh Lavornia

    Politics Editor 2017-19

    Related Posts

    Redevelopment plans and the culture of Bangor

    October 28, 2022

    Immediate closure of Menai Bridge following reports of structural integrity issues

    October 28, 2022

    Racial abuse victim calls for harsher sentencing following nightclub assault

    October 28, 2022

    Leave A Reply Cancel Reply

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    MORE INFORMATION
    • ABOUT
    • ADVERTISE
    • CONTACT US
    • GET INVOLVED
    • MEMBERS
    Links
    • Bangor University Bangor University
    • Google+ Google+
    • Undeb Bangor Undeb Bangor
    About

    Seren is Bangor University Students’ Union’s English Language Newspaper

    We have editorial independence from both Bangor University and Bangor Students’ Union. Seren is written by students for students and we’d love you to get involved!

    Type above and press Enter to search. Press Esc to cancel.